Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Kemp

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
Breast Cancer Research and Treatment|December 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCYJudith Balmaña, Peter A Fasching, Fergus J Couch, et al.
Nature Genetics|July 10, 2007
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21Ian Tomlinson, Emily Webb, Luis Carvajal-Carmona, et al.
Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.
Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.
European Journal of Human Genetics : EJHG|July 17, 2008
Deciphering the genetics of hereditary non-syndromic colorectal cancerEli Papaemmanuil, Luis Carvajal-Carmona, Gabrielle S Sellick, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2026
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trialJohn Burn, Gillian M Borthwick, Faye Elliott, et al.
Nature Genetics|December 25, 2012
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomasClaire Palles, Jean-Baptiste Cazier, Kimberley M Howarth, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Medical Genetics|July 22, 2022
A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilotBethany Torr, Christopher Jones, Subin Choi, et al.
Breast Cancer Research and Treatment|December 19, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCYJudith Balmaña, Peter A Fasching, Fergus J Couch, et al.
Nature Genetics|July 10, 2007
A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21Ian Tomlinson, Emily Webb, Luis Carvajal-Carmona, et al.
Nature Genetics|October 16, 2007
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer riskPeter Broderick, Luis Carvajal-Carmona, Alan M Pittman, et al.
Nature Genetics|December 18, 2007
Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer riskEmma Jaeger, Emily Webb, Kimberley Howarth, et al.
European Journal of Human Genetics : EJHG|July 17, 2008
Deciphering the genetics of hereditary non-syndromic colorectal cancerEli Papaemmanuil, Luis Carvajal-Carmona, Gabrielle S Sellick, et al.
Breast Cancer Research : BCR|May 21, 2025
Distribution of age at natural menopause, age at menarche, menstrual cycle length, height and BMI in BRCA1 and BRCA2 pathogenic variant carriers and non-carriers: results from EMBRACENasim Mavaddat, Debra Frost, Emily Zhao, et al.
The Lancet. Gastroenterology & Hepatology|July 9, 2026
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trialJohn Burn, Gillian M Borthwick, Faye Elliott, et al.
Nature Genetics|December 25, 2012
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomasClaire Palles, Jean-Baptiste Cazier, Kimberley M Howarth, et al.
Journal of Medical Genetics|June 4, 2024
Validation of the BOADICEA model in a prospective cohort of <i>BRCA1/2</i> pathogenic variant carriersXin Yang, Thea M Mooij, Goska Leslie, et al.
Pageof 4